Claim Missing Document
Check
Articles

Found 2 Documents
Search

ANTI HCV DAN JUMLAH PENDERITA JANGKITAN (PREVALENSI INFEKSI) VIRUS HEPATITIS C Isti Setijorini Wulandari; Kismardhani .
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 16, No 1 (2009)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v16i1.993

Abstract

ABSTRACTIn various prevalence Hepatitis C Virus (HCV) infections was found all over the world. There is no accurate data about the spreading of HCV infection in Indonesia. Indonesian Department of Health makes a program to make a database from all provinces in Indonesiaabout prevalence of HCV. This is supported by request from the district Health Department of Daerah Istimewa Yogyakarta (DIY)Province to conduct HCV infection surveillance in 2007. Data of HCV infection from blood transfusion service show approximately 2%.To complete the basic data by knowing the prevalence of HCV in Dr. Sardjito General Hospital Yogyakarta at DIY province. This is an Hospital Yogyakarta at DIY province. This is anHospital Yogyakarta at DIY province. This is an observational descriptive study about HCV infection prevalence in Dr. Sardjito General Hospital Yogyakarta. Data was collected fromSeptember 2007−August 2008 conducted on Microbiology, Immunology & Infection Sub Laboratory of Clinical Pathology Departmentin Dr Sardjito General Hospital Yogyakarta. There was 753 request of anti HCV test from September 2007−August 2008. Initial reactiveresult was found in 131 patients. In the first quarter in 2007 (January−April 2007) there were 27 initial reactive from 175 samples ofanti HCV test (15.42%). In the second quarter were found 36 initial reactive out of 176 samples of anti HCV test (20.45%) and in thelast trimester in 2007 were found 19 initial reactive out of 134 samples (14.17%). In 2008, first quarter were found 21 positive resultout of 123 samples (17.03%) and in the second quarter (May−August 2008) were found 32 positive result out of 145 samples (22.06%).There are gradually increased percentage rates of initial reactive anti HCV test based on the result from each trimester HCV test based on the result from each trimesterHCV test based on the result from each trimester (15.42−20%, 45−14 %, 17−17%, 03−22.06%)
KORELASI ANTARA NEURON-SPECIFIC ENOLASE SERUM DAN GLASGOW COMA SCALE DI PASIEN CEDERA KEPALA Usi Sukorini; Isti Setijorini Wulandari; Budi Mulyono; Handoyo Pramusinto
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 17, No 1 (2010)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v17i1.1043

Abstract

The outcome after head injury is mostly determined by Glasgow Coma Scale (GCS) and the degree of brain damage which reveals.CT scan is also important to assess its severity. However relatively it is not in a less costly manner and sometimes patients mobilisationare needed. Brain damage due to traumatic head injury refers to homeostasis unbalance, and it is the important causes of releasingbiochemical analyte from neuron via injured blood brain barrier to circulation. Neuron-specific enolase as a glycolytic enzyme in neuroncytoplasm might increase. Hopefully, measurement of NSE levels can provide information about the extent of the disease. The objectiveof the study is to test the correlation between the Neuron Specific Enolase (NSE) serum as a one of biochemical marker of brain injuryand the GCS. For this purpose, a cross sectional, analytical observasional study was carried out at the Emergency Departement andDepartement of Clinical Laboratory, Sardjito General Hospital, Yogyakarta, Indonesia. Fifty-one patients selected by an eligible criteriawere included in the study, which consist of severe, moderate and mild head injury. Blood samples were collected and serum NSE wasmeasured by immunoanalyzer using Electro Cheluminescence ImmunoAssay (ECLIA). Chi square test was used to test the differenceproportion of the group: NSE ≥ 21.7 ng/mL and NSE < 21.7 ng/mL according to measured variables, and Spearman correlation testwas used to correlate serum NSE and GCS, and other variables. In the study fifty-one patients with head injury were included, 74.5%of patients were males and 68.6% is in the age of 15–45 years old. The patients were further divided into two groups on the basis ofserum NSE ≥ 21.7 ng/mL and < 21.7 ng/mL; the former group was dominated by severe head injury patients (54.1%). In addition, aproportion of non survivors (66.6%) in group NSE ≥ 21.7 ng/mL was higher compared to those in NSE < 21.7 ng/mL group. Moreover,a large number of mild head injury (95.45%) and survivors (83.33%) had lower serum NSE (< 21.7 ng/mL). In the study, was found anegative correlation between serum NSE and GCS (r = -0.552; p = 0.00). Also, serum NSE were inversely correlated with blood kaliumand hemoglobin (r = -0.162; p = 0.027 dan r = -0.376; p = 0.009), in contrast with leucocytes count (r = 0.485; p = 0.001). Theconclusion so far there was a negative correlation between serum NSE and GCS. It is suggested that neuron-specific enolase can be veryuseful as a biochemical marker in assesssing the severity of head injury. Therefore, it is nessessary to carry out the prognostic study toknow to what extent it can predicting the outcomes.